Big Idea

Craig Crews, Yale University
Glympse Bio
Kytopen
Rodin Therapeutics
Talaris Therapeutics

CEO

Aoife Brennan, Synlogic
Doug Ingram, Sarepta Therapeutics
Jeff Jonas, Sage Therapeutics
Matt Kapusta, UniQure
Jason Kelly, Ginkgo Bioworks
Praveen Tipirneni, Morphic Therapeutic

Commitment to Diversity

BioDirector
Melodie Knowlton, Vertex Learning Lab
Life Science Cares
Massachusetts Next Generation Initiative
Joseph Vogel, Alnylam Pharmaceuticals

Digital Trailblazer

Regina Barzilay, MIT
Catalog
DynamiCare Health
Loro
Mightier/Neuromotion Labs

Innovation at the Intersection

Beta Bionics
Cellino
Relay Therapeutics
Vaxess Technologies

Newcomer

Alexion Pharmaceuticals
Pablo Cagnoni, Rubius Therapeutics
David Epstein, Flagship Pioneering
Jackie Fouse, Agios Pharmaceuticals
Ipsen Biopharmaceuticals
Caroline Loew, Glympse Bio

Patients First

JDRF T1D Fund
Linnea Olson, HMS Executive Education
Sobi (North America)

Secret Weapon

Joseph Bolen, PureTech Health
Kimi Iguchi, Sage Therapeutics
Joseph Kim, Blueprint Medicines
Sarah MacDonald, Life Science Cares

Startup

Entrada Therapeutics
Goldfinch Bio
IFM Therapeutics
Kyn Therapeutics
Lyndra Therapeutics
Sherlock Biosciences
Skyhawk Therapeutics

X of the Year

Advocate
Phil Kongtcheu, eMotionRx

Cancer Investigator
Stefani Spranger, MIT

Cell Therapy Platform
Vor Biopharma

Founder-Investor
Patrick Baeuerle, MPM Capital

Startup Artist
Greg Verdine, FogPharma & LifeMine Therapeutics

Resurrection
Ginkgo Bioworks

Young Innovator

Joshua Cohen & Justin Klee, Amylyx Pharmaceuticals
Cheryl Cui, Nest.Bio Labs
Stephan Kontos, Anokion
Jordi Mata-Fink, Flagship Pioneering
Leila Pirhaji, ReviveMed